Your browser doesn't support javascript.
loading
A novel thieno[2,3-d]pyrimidine derivative inhibiting vascular endothelial growth factor receptor-2: A story of computer-aided drug discovery.
Sobh, Eman A; Dahab, Mohammed A; Elkaeed, Eslam B; Alsfouk, Bshra A; Ibrahim, Ibrahim M; Metwaly, Ahmed M; Eissa, Ibrahim H.
Afiliação
  • Sobh EA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Menoufia University, Menoufia, Shibin-Elkom, Egypt.
  • Dahab MA; Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt.
  • Elkaeed EB; Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh, Saudi Arabia.
  • Alsfouk BA; Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
  • Ibrahim IM; Biophysics Department, Faculty of Science, Cairo University, Cairo, Egypt.
  • Metwaly AM; Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt.
  • Eissa IH; Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria, Egypt.
Drug Dev Res ; 84(6): 1247-1265, 2023 09.
Article em En | MEDLINE | ID: mdl-37232504

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Drug Dev Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Drug Dev Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito